Compare IDEXX Laboratories, Inc. (IDXX) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Illinois Tool Works Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Illinois Tool Works Inc. trades at $264.13 (market cap $74.38B). The key difference: Illinois Tool Works Inc. is the larger of the two by market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Illinois Tool Works Inc. for 67 Days on average.
| IDXX | ITW | |
|---|---|---|
Market Cap | $40.43B | $74.38B |
Volume | 692,164 | 1,125,477 |
Sector | Health | Industrials |
52-Week High | $766.68 | $299.60 |
52-Week Low | $504.70 | $241.07 |
Typical Hold Time | 46 Days | 67 Days |
Enterprise Value | $41.32B | $83.23B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
ITW trades at $264.71, up 1.36% today, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $2.84, beating estimates, and maintains robust profitability with a 19.39% net income margin and 104.65% ROE. Recent news highlights its dividend increase to $1.72 per share and its status as a Dividend King with 59 years of consecutive increases.
The outlook is mixed: strong cash flow and dividend reliability support income investors, but high valuation ratios (P/E 23.65, P/B 25.7) and bearish technicals suggest near-term pressure. Risks include debt levels and sector volatility, while analyst consensus leans hold with a $276.86 price target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
